Insider · CIK 0001710237
Julie B Feder
Files at AURA (Aura Biosciences, Inc.). First filing Oct 21, 2024, latest Oct 21, 2024.
In brief
Julie B Feder files SEC Form 4 as CFO at AURA (Aura Biosciences, Inc.). Since Oct 21, 2024, Julie B Feder has reported 0 open-market buys worth $0 and 1 open-market sell worth $302k, the latest filed on Oct 21, 2024.
A track record needs three past buys with six months of prices behind them; Julie B Feder has 0, so none is measured yet.
The newest scored trade: sold $302k of AURA on Oct 18, 2024, filed Oct 21, 2024, scored 21 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AURA: Aura Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | Aura Biosciences, Inc. | $302k 25,131 shares | -16% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 29, 2024 | AURA Aura Biosciences, Inc. | 3,249 0.01% of outstanding | $35k | Oct 29, 2024 | $216k |
| Oct 18, 2024 | AURA AURA BIOSCIENCES INC | 25,131 0.05% of outstanding | $259k | Oct 18, 2024 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 18, 2024 | AURA Aura Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +17,500 | $2.74 | $48k | 151,776 | Oct 21, 2024 |
| Oct 18, 2024 | AURA Aura Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +2,631 | $4.25 | $11k | 154,407 | Oct 21, 2024 |
| Oct 18, 2024 | AURA Aura Biosciences, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | $5.48 | $27k | 159,407 | Oct 21, 2024 |
| Oct 18, 2024 | AURA Aura Biosciences, Inc. | SOpen-market sale Common Stock10b5-1 | -25,131 | $12.03 | $302k | 134,276 | Oct 21, 2024 |
| Oct 18, 2024 | AURA Aura Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -17,500 | $0.00 | $0 | 68,257 | Oct 21, 2024 |
| Oct 18, 2024 | AURA Aura Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -2,631 | $0.00 | $0 | 32,359 | Oct 21, 2024 |
| Oct 18, 2024 | AURA Aura Biosciences, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 120,547 | Oct 21, 2024 |
Questions about Julie B Feder
Answered from the filings on this page, as of the latest one.
Is Julie B Feder buying or selling?
Not in the last 12 months. Julie B Feder's latest open-market trade on SEC Form 4 was sold $302k of AURA on Oct 18, 2024.
How did Julie B Feder's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Julie B Feder has 0.
Where does Julie B Feder file Form 4?
Julie B Feder has filed Form 4 at AURA (Aura Biosciences, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.